UK's Latest Cancer Drug Cull Draws Renewed Calls For Reform
This article was originally published in Scrip
Executive Summary
New cuts to publicly funded NHS oncology treatments announced in Britain have triggered fresh criticisms of the government's Cancer Drugs Fund and renewed calls for a system-wide overhaul of the way cancer drugs are commissioned in the country.